---
document_datetime: 2023-09-21 19:33:17
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/eperzan-epar-all-authorised-presentations_en.pdf
document_name: eperzan-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0338953
conversion_datetime: 2025-12-20 08:01:34.672807
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                           | Route of Administration   | Immediate Packaging                                       | Content                       | Pack size                                                        |
|------------------|-------------------|------------|-----------------------------------------------|---------------------------|-----------------------------------------------------------|-------------------------------|------------------------------------------------------------------|
| EU/1/13/908/001  | Eperzan           | 30 mg      | Powder and solvent for solution for injection | Subcutaneous use          | Dual Chamber Cartridge (DCC) in pre-filled pen            | Powder: 30 mg Solvent: 0.5 ml | 4 pre-filled pens + 4 pen needles                                |
| EU/1/13/908/002  | Eperzan           | 50 mg      | Powder and solvent for solution for injection | Subcutaneous use          | Dual Chamber Cartridge (DCC) in pre-filled pen authorised | Powder: 50 mg Solvent: 0.5 ml | 4 pre-filled pens + 4 pen needles                                |
| EU/1/13/908/003  | Eperzan           | 30 mg      | Powder and solvent for solution for injection | Subcutaneous use          | Dual Chamber Cartridge (DCC) in pre-filled pen            | Powder: 30 mg Solvent: 0.5 ml | 12 (3 x 4) pre- filled pens + 12 (3 x 4) pen needles (multipack) |
| EU/1/13/908/004  | Eperzan           | 50 mg      | Powder and solvent for solution for injection | Subcutaneous use          | Dual Chamber Cartridge (DCC) in pre-filled pen            | Powder: 50 mg Solvent: 0.5 ml | 12 (3 x 4) pre- filled pens + 12 (3 x 4) pen needles (multipack) |

## (Invented) name Strength Pharmaceutical Form Route of Administration Eperzan 30 mg Powder and solvent for solution for injection Subcutaneous use Eperzan 50 mg Powder and solvent for solution for injection Subcutaneous use Eperzan 30 mg Powder and solvent for solution for injection Subcutaneous use Eperzan 50 mg Powder and solvent for solution for injection Subcutaneous use Medicinal product no longer authorised